NOVAFLUX TECHNOLOGIES, INC.

Company Information
Address 1 WALL ST
PRINCETON, NJ, -


Information

DUNS: 943652065

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics

    Amount: $1,999,998.00

    DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The Eur ...

    SBIRPhase II2012Department of Health and Human Services
  2. Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics

    Amount: $2,299,998.00

    DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The Eur ...

    SBIRPhase I2011Department of Health and Human Services
  3. A Novel Device for Managing Hypervolemia in CHF Patients

    Amount: $599,978.00

    DESCRIPTION (provided by applicant): We discovered a new modality that will allow us to effectively remove excess fluid from patients and manage hypervolemia. Accordingly, we propose the development o ...

    SBIRPhase I2010Department of Health and Human Services
  4. Novel biofilm polymicrobial infection-resistant implants for otologic application

    Amount: $1,239,300.00

    DESCRIPTION (provided by applicant): Over one-quarter of all oral antibiotics prescribed in the United States are for acute otitis media. Tympanostomy tube (TT) insertion has become the treatment of c ...

    SBIRPhase II2009Department of Health and Human Services
  5. Biofilm polymicrobial infection-resistant implants for otologic application

    Amount: $161,470.00

    DESCRIPTION (provided by applicant): Over one-quarter of all oral antibiotics is prescribed for acute otitis media in the United States. Myringotomy with tympanostomy tube insertion has become the tre ...

    SBIRPhase I2007Department of Health and Human Services
  6. Novel Technology for Reprocessing Flexible Endoscopes

    Amount: $2,302,820.00

    DESCRIPTION (provided by applicant): Since inadequate cleaning is the main cause of failure in sterilizing flexible endoscopes, cardinal modification of existing cleaning methods is urgently needed. D ...

    SBIRPhase II2006Department of Health and Human Services
  7. Device for Eradicating /Controlling Biofilm in Dialysis

    Amount: $1,099,410.00

    DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in hemodialysis patients due to exposure to endotoxins has become a central issue in nephrology in ...

    SBIRPhase II2005Department of Health and Human Services
  8. Device for Eradicting & Controlling Biofilm in Dialysis

    Amount: $138,544.00

    DESCRIPTION (provided by applicant): Hemodialysis is a water intensive therapy that presents an enormous challenge to cost effectively produce very large amounts of high purity water. The occurrenc ...

    SBIRPhase I2004Department of Health and Human Services
  9. Low Temp Decontamination/Sterilize/Dental Handpieces

    Amount: $0.00

    DESCRIPTION: (provided by the applicant) Frequent repair and replacement of dental handpieces (DHs) represent major dental practice costs necessitating an immediate technological solution. Dental hand ...

    SBIRPhase I2004Department of Health and Human Services
  10. Low Temp Decontamination/Sterilize/Dental Handpieces

    Amount: $786,406.00

    DESCRIPTION: (provided by the applicant) Frequent repair and replacement of dental handpieces (DHs) represent major dental practice costs necessitating an immediate technological solution. Dental hand ...

    SBIRPhase II2004Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government